Deeter Investments’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Deeter Investments's SMMT Position: Q3 2026 in Review
Deeter Investments opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 169,740 shares worth $2.87M. The stake represents 0.4% of the portfolio and ranks #58 among its holdings.
298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Deeter Investments held 169,740 shares of Summit Therapeutics worth $2.87M as of Q3 2026.
- Summit Therapeutics was a new Deeter Investments position in Q3 2026.
- Summit Therapeutics made up 0.4% of Deeter Investments's portfolio in Q3 2026, its #58 holding.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Deeter Investments's 13F filing for Q3 2026, filed 16 Nov 2026.